Robbert van der Most

9.7k total citations · 1 hit paper
92 papers, 6.1k citations indexed

About

Robbert van der Most is a scholar working on Immunology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Robbert van der Most has authored 92 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Immunology, 33 papers in Infectious Diseases and 28 papers in Epidemiology. Recurrent topics in Robbert van der Most's work include Immunotherapy and Immune Responses (34 papers), Immune Cell Function and Interaction (21 papers) and SARS-CoV-2 and COVID-19 Research (20 papers). Robbert van der Most is often cited by papers focused on Immunotherapy and Immune Responses (34 papers), Immune Cell Function and Interaction (21 papers) and SARS-CoV-2 and COVID-19 Research (20 papers). Robbert van der Most collaborates with scholars based in Belgium, United States and Netherlands. Robbert van der Most's co-authors include Rafi Ahmed, Kaja Murali‐Krishna, E. John Wherry, Joseph N. Blattman, Richard Lake, Willy J. M. Spaan, Andrew Currie, Raoul J. de Groot, Bruce Robinson and J. Lindsay Whitton and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Robbert van der Most

92 papers receiving 6.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Viral Persistence Alters CD8 T-Cell Immunodominance and Tissue Distribution and Results in Distinct Stages of Functional Impairment

2003 1.3k citations E. John Wherry, Joseph N. Blattman et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Robbert van der Most	3.7k	1.6k	1.5k	1.1k	936	92	6.1k
Allan Randrup Thomsen	4.4k 1.2×	1.6k 1.0×	1.2k 0.8×	1.0k 0.9×	940 1.0×	178	6.6k
M. Suresh	5.2k 1.4×	1.6k 1.0×	1.1k 0.7×	1.2k 1.1×	1.0k 1.1×	103	7.2k
Rune Hartmann	4.8k 1.3×	1.9k 1.1×	2.2k 1.4×	1.0k 0.9×	2.7k 2.9×	99	8.0k
Jovan Pavlovic	4.7k 1.3×	2.5k 1.5×	1.8k 1.2×	1.1k 1.1×	2.3k 2.4×	84	8.2k
Gottfried Alber	4.4k 1.2×	1.7k 1.0×	1.2k 0.8×	665 0.6×	955 1.0×	103	6.7k
Yueh–Ming Loo	6.6k 1.8×	2.6k 1.6×	2.2k 1.4×	1.0k 0.9×	3.2k 3.4×	50	9.4k
Samuel Baron	2.9k 0.8×	2.3k 1.4×	1.1k 0.7×	1.1k 1.0×	1.2k 1.2×	216	6.6k
Joan E. Durbin	5.1k 1.4×	3.2k 2.0×	1.6k 1.1×	2.2k 2.0×	1.7k 1.8×	83	8.6k
Andreas Jung	4.4k 1.2×	1.3k 0.8×	1.1k 0.7×	530 0.5×	2.0k 2.2×	40	6.1k
Kaja Murali‐Krishna	9.5k 2.6×	2.2k 1.4×	1.4k 0.9×	1.9k 1.7×	1.5k 1.6×	74	11.7k

Countries citing papers authored by Robbert van der Most

Since Specialization

Citations

This map shows the geographic impact of Robbert van der Most's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robbert van der Most with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robbert van der Most more than expected).

Fields of papers citing papers by Robbert van der Most

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robbert van der Most. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robbert van der Most. The network helps show where Robbert van der Most may publish in the future.

Co-authorship network of co-authors of Robbert van der Most

This figure shows the co-authorship network connecting the top 25 collaborators of Robbert van der Most. A scholar is included among the top collaborators of Robbert van der Most based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robbert van der Most. Robbert van der Most is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Loos, Carolin, Margherita Coccia, Arnaud M. Didierlaurent, et al.. (2023). Systems serology-based comparison of antibody effector functions induced by adjuvanted vaccines to guide vaccine design. npj Vaccines. 8(1). 34–34. 14 indexed citations

Bruxvoort, Katia, Bradley K. Ackerson, Lina S. Sy, et al.. (2021). Recombinant Adjuvanted Zoster Vaccine and Reduced Risk of Coronavirus Disease 2019 Diagnosis and Hospitalization in Older Adults. The Journal of Infectious Diseases. 225(11). 1915–1922. 30 indexed citations

Buricchi, Francesca, Patricia Bourguignon, Ugo D’Oro, et al.. (2021). Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants. npj Vaccines. 6(1). 78–78. 34 indexed citations

Mot, Laurane De, Viviane Bechtold, Vanesa Bol, et al.. (2020). Transcriptional profiles of adjuvanted hepatitis B vaccines display variable interindividual homogeneity but a shared core signature. Science Translational Medicine. 12(569). 33 indexed citations

Laupèze, Béatrice, Robbert van der Most, & Giuseppe Del Giudice. (2020). Novel Technologies to Improve Vaccines for Older Adults. PubMed. 43. 218–233. 2 indexed citations

Ryser, Martin, et al.. (2019). Post-hoc analysis from phase III trials of human papillomavirus vaccines: considerations on impact on non-vaccine types. Expert Review of Vaccines. 18(3). 309–322. 17 indexed citations

Alden, Kieran, Margherita Coccia, Aurélie Chalon, et al.. (2019). Application of Modeling Approaches to Explore Vaccine Adjuvant Mode-of-Action. Frontiers in Immunology. 10. 2150–2150. 5 indexed citations

Galson, Jacob D., Johannes Trück, Anna Fowler, et al.. (2015). Analysis of B Cell Repertoire Dynamics Following Hepatitis B Vaccination in Humans, and Enrichment of Vaccine-specific Antibody Sequences. EBioMedicine. 2(12). 2070–2079. 68 indexed citations

Andrews, Daniel M., Marie J. Estcourt, Christopher E. Andoniou, et al.. (2010). Innate immunity defines the capacity of antiviral T cells to limit persistent infection. The Journal of Experimental Medicine. 207(6). 1333–1343. 173 indexed citations

10.

Most, Robbert van der, Amy Prosser, Michaël G. Tovey, et al.. (2009). Locally Administered TLR7 Agonists Drive Systemic Antitumor Immune Responses That Are Enhanced by Anti-CD40 Immunotherapy. The Journal of Immunology. 182(9). 5217–5224. 77 indexed citations

11.

Currie, Andrew, Amy Prosser, Alison M. McDonnell, et al.. (2009). Dual Control of Antitumor CD8 T Cells through the Programmed Death-1/Programmed Death-Ligand 1 Pathway and Immunosuppressive CD4 T Cells: Regulation and Counterregulation. The Journal of Immunology. 183(12). 7898–7908. 48 indexed citations

12.

Nowak, Anna K., et al.. (2008). Cisplatin and pemetrexed synergises with immunotherapy to result in cures in established murine malignant mesothelioma. Cancer Research. 68. 2073–2073. 3 indexed citations

13.

Lukens, Michaël V., E Claassen, Mariska E. A. van Dijk, et al.. (2006). Characterization of the CD8+ T cell responses directed against respiratory syncytial virus during primary and secondary infection in C57BL/6 mice. Virology. 352(1). 157–168. 48 indexed citations

14.

Claassen, E, et al.. (2005). Activation and Inactivation of Antiviral CD8 T Cell Responses during Murine Pneumovirus Infection. The Journal of Immunology. 175(10). 6597–6604. 38 indexed citations

15.

Heidema, Jojanneke, Martien C. M. Poelen, Mariska E. A. van Dijk, et al.. (2004). HLA-DP4 presents an immunodominant peptide from the RSV G protein to CD4 T cells. Virology. 326(2). 220–230. 17 indexed citations

16.

Most, Robbert van der. (2003). Changing immunodominance patterns in antiviral CD8 T-cell responses after loss of epitope presentation or chronic antigenic stimulation. Virology. 1 indexed citations

17.

Most, Robbert van der, Kaja Murali‐Krishna, J. Gibson Lanier, et al.. (2003). Changing immunodominance patterns in antiviral CD8 T-cell responses after loss of epitope presentation or chronic antigenic stimulation. Virology. 315(1). 93–102. 85 indexed citations

18.

Most, Robbert van der, et al.. (2002). Yellow Fever Virus 17D Envelope and NS3 Proteins Are Major Targets of the Antiviral T Cell Response in Mice. Virology. 296(1). 117–124. 49 indexed citations

19.

Most, Robbert van der, Jeroen Corver, & J H Strauss. (1999). Mutagenesis of the RGD Motif in the Yellow Fever Virus 17D Envelope Protein. Virology. 265(1). 83–95. 55 indexed citations

20.

Most, Robbert van der, Kaja Murali‐Krishna, J. Lindsay Whitton, et al.. (1998). Identification of Db- and Kb-Restricted Subdominant Cytotoxic T-Cell Responses in Lymphocytic Choriomeningitis Virus-Infected Mice. Virology. 240(1). 158–167. 141 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact